Your browser doesn't support javascript.
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
Corman, Victor M; Landt, Olfert; Kaiser, Marco; Molenkamp, Richard; Meijer, Adam; Chu, Daniel Kw; Bleicker, Tobias; Brünink, Sebastian; Schneider, Julia; Schmidt, Marie Luisa; Mulders, Daphne Gjc; Haagmans, Bart L; van der Veer, Bas; van den Brink, Sharon; Wijsman, Lisa; Goderski, Gabriel; Romette, Jean-Louis; Ellis, Joanna; Zambon, Maria; Peiris, Malik; Goossens, Herman; Reusken, Chantal; Koopmans, Marion Pg; Drosten, Christian.
  • Corman VM; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany.
  • Landt O; Tib-Molbiol, Berlin, Germany.
  • Kaiser M; GenExpress GmbH, Berlin, Germany.
  • Molenkamp R; Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
  • Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Chu DK; University of Hong Kong, Hong Kong, China.
  • Bleicker T; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany.
  • Brünink S; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany.
  • Schneider J; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany.
  • Schmidt ML; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany.
  • Mulders DG; Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
  • Haagmans BL; Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
  • van der Veer B; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • van den Brink S; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Wijsman L; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Goderski G; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Romette JL; Universite d Aix-Marseille, Marseille, France.
  • Ellis J; Public Health England, London, United Kingdom.
  • Zambon M; Public Health England, London, United Kingdom.
  • Peiris M; University of Hong Kong, Hong Kong, China.
  • Goossens H; Department of Medical Microbiology, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium.
  • Reusken C; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Koopmans MP; Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
  • Drosten C; Charité - Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany.
Euro Surveill ; 25(3)2020 01.
Article in English | MEDLINE | ID: covidwho-1004613
ABSTRACT

BACKGROUND:

The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur.

AIM:

We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available.

METHODS:

Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology.

RESULTS:

The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project.

CONCLUSION:

The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus Infections / Coronavirus / Clinical Laboratory Techniques Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.Es.2020.25.3.2000045

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus Infections / Coronavirus / Clinical Laboratory Techniques Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal subject: Communicable Diseases Year: 2020 Document Type: Article Affiliation country: 1560-7917.Es.2020.25.3.2000045